Motohiro Sekiya

5.1k total citations
58 papers, 2.5k citations indexed

About

Motohiro Sekiya is a scholar working on Surgery, Molecular Biology and Epidemiology. According to data from OpenAlex, Motohiro Sekiya has authored 58 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Surgery, 29 papers in Molecular Biology and 11 papers in Epidemiology. Recurrent topics in Motohiro Sekiya's work include Cholesterol and Lipid Metabolism (23 papers), Peroxisome Proliferator-Activated Receptors (17 papers) and Lipid metabolism and biosynthesis (11 papers). Motohiro Sekiya is often cited by papers focused on Cholesterol and Lipid Metabolism (23 papers), Peroxisome Proliferator-Activated Receptors (17 papers) and Lipid metabolism and biosynthesis (11 papers). Motohiro Sekiya collaborates with scholars based in Japan, United States and France. Motohiro Sekiya's co-authors include Hitoshi Shimano, Shun Ishibashi, Jun-ichi Osuga, Naoya Yahagi, Takashi Matsuzaka, Nobuhiro Yamada, Ryozo Nagai, Hiroaki Okazaki, Ken Ohashi and Yoko Iizuka and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Motohiro Sekiya

56 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Motohiro Sekiya Japan 27 1.2k 746 615 532 506 58 2.5k
Kazuhisa Tsukamoto Japan 30 1.6k 1.3× 911 1.2× 960 1.6× 436 0.8× 311 0.6× 103 3.5k
Tomohiro Ide Japan 22 1.5k 1.2× 752 1.0× 641 1.0× 813 1.5× 327 0.6× 29 2.6k
Akimitsu Takahashi Japan 31 1.7k 1.4× 661 0.9× 1.4k 2.2× 647 1.2× 595 1.2× 46 3.5k
Pierre‐Damien Denechaud France 17 1.2k 1.0× 609 0.8× 552 0.9× 428 0.8× 271 0.5× 27 2.0k
Pascale Bossard France 17 1.7k 1.4× 446 0.6× 1.1k 1.7× 340 0.6× 503 1.0× 31 2.9k
Marta Casado Spain 28 1.0k 0.8× 449 0.6× 442 0.7× 329 0.6× 369 0.7× 75 2.3k
Sachiko Tomita Japan 12 863 0.7× 412 0.6× 564 0.9× 375 0.7× 377 0.7× 14 1.8k
Fatiha Nassir United States 23 935 0.8× 913 1.2× 465 0.8× 528 1.0× 206 0.4× 43 2.5k
Sanja Levak‐Frank Austria 27 1.1k 0.9× 294 0.4× 734 1.2× 762 1.4× 284 0.6× 41 2.7k

Countries citing papers authored by Motohiro Sekiya

Since Specialization
Citations

This map shows the geographic impact of Motohiro Sekiya's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Motohiro Sekiya with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Motohiro Sekiya more than expected).

Fields of papers citing papers by Motohiro Sekiya

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Motohiro Sekiya. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Motohiro Sekiya. The network helps show where Motohiro Sekiya may publish in the future.

Co-authorship network of co-authors of Motohiro Sekiya

This figure shows the co-authorship network connecting the top 25 collaborators of Motohiro Sekiya. A scholar is included among the top collaborators of Motohiro Sekiya based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Motohiro Sekiya. Motohiro Sekiya is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Sekiya, Motohiro, et al.. (2023). C-Terminal Binding Protein 2 Emerges as a Critical Player Linking Metabolic Imbalance to the Pathogenesis of Obesity. Journal of Atherosclerosis and Thrombosis. 31(2). 109–116. 2 indexed citations
3.
Yatoh, Shigeru, et al.. (2022). L-Asparaginase-Induced Continuous Hyperglycemia With Type 1 Diabetes-Related Antibodies and HLA Genotypes: A Case Study. Cureus. 14(10). e30067–e30067. 2 indexed citations
4.
Sekiya, Motohiro, Yuki Yamamoto, Yuki Murayama, et al.. (2020). Deciphering genetic signatures by whole exome sequencing in a case of co-prevalence of severe renal hypouricemia and diabetes with impaired insulin secretion. BMC Medical Genetics. 21(1). 91–91. 3 indexed citations
5.
Ohno, Hiroshi, Takashi Matsuzaka, Rahul Sharma, et al.. (2018). Transgenic Mice Overexpressing SREBP-1a in Male ob/ob Mice Exhibit Lipodystrophy and Exacerbate Insulin Resistance. Endocrinology. 159(6). 2308–2323. 15 indexed citations
6.
Furukawa, Shoko, Hiroaki Suzuki, Kazuya Fujihara, et al.. (2018). Malondialdehyde-modified LDL-related variables are associated with diabetic kidney disease in type 2 diabetes. Diabetes Research and Clinical Practice. 141. 237–243. 13 indexed citations
7.
Nakagawa, Yoshimi, Yunong Wang, Song‐iee Han, et al.. (2017). Effects of K-877, a novel selective PPARα modulator, on small intestine contribute to the amelioration of hyperlipidemia in low-density lipoprotein receptor knockout mice. Journal of Pharmacological Sciences. 133(4). 214–222. 38 indexed citations
8.
Han, Song‐iee, Yuki Murayama, Aoi Satoh, et al.. (2017). Selective peroxisome proliferator‐activated receptor‐α modulator K‐877 efficiently activates the peroxisome proliferator‐activated receptor‐α pathway and improves lipid metabolism in mice. Journal of Diabetes Investigation. 8(4). 446–452. 34 indexed citations
9.
Zhao, Hui, Takashi Matsuzaka, Yuta Nakano, et al.. (2017). Elovl6 Deficiency Improves Glycemic Control in Diabetic db/db Mice by Expanding β-Cell Mass and Increasing Insulin Secretory Capacity. Diabetes. 66(7). 1833–1846. 30 indexed citations
10.
Kikuchi, Takuya, Song‐iee Han, Motoko Kuba, et al.. (2016). Intestinal CREBH overexpression prevents high-cholesterol diet-induced hypercholesterolemia by reducing Npc1l1 expression. Molecular Metabolism. 5(11). 1092–1102. 33 indexed citations
11.
Sekiya, Motohiro, Jun-ichi Osuga, Masaki Igarashi, Hiroaki Okazaki, & Shun Ishibashi. (2011). The Role of Neutral Cholesterol Ester Hydrolysis in Macrophage Foam Cells. Journal of Atherosclerosis and Thrombosis. 18(5). 359–364. 51 indexed citations
12.
Ohta, Keisuke, Motohiro Sekiya, Hiroshi Uozaki, et al.. (2010). Abrogation of neutral cholesterol ester hydrolytic activity causes adrenal enlargement. Biochemical and Biophysical Research Communications. 404(1). 254–260. 7 indexed citations
13.
Igarashi, Masaki, Jun-ichi Osuga, Masashi Isshiki, et al.. (2009). Targeting of neutral cholesterol ester hydrolase to the endoplasmic reticulum via its N-terminal sequence. Journal of Lipid Research. 51(2). 274–285. 26 indexed citations
14.
Sekiya, Motohiro, Jun-ichi Osuga, Naoya Yahagi, et al.. (2008). Hormone-sensitive lipase is involved in hepatic cholesteryl ester hydrolysis. Journal of Lipid Research. 49(8). 1829–1838. 49 indexed citations
15.
Sekiya, Motohiro, Naoya Yahagi, Takashi Matsuzaka, et al.. (2007). SREBP-1-independent regulation of lipogenic gene expression in adipocytes. Journal of Lipid Research. 48(7). 1581–1591. 109 indexed citations
16.
Yahagi, Naoya, Hitoshi Shimano, Kiyoshi Hasegawa, et al.. (2005). Co-ordinate activation of lipogenic enzymes in hepatocellular carcinoma. European Journal of Cancer. 41(9). 1316–1322. 205 indexed citations
17.
Najima, Yuho, Naoya Yahagi, Yoshinori Takeuchi, et al.. (2005). High Mobility Group Protein-B1 Interacts with Sterol Regulatory Element-binding Proteins to Enhance Their DNA Binding. Journal of Biological Chemistry. 280(30). 27523–27532. 36 indexed citations
18.
Yahagi, Naoya, Hitoshi Shimano, Takashi Matsuzaka, et al.. (2004). p53 Involvement in the Pathogenesis of Fatty Liver Disease. Journal of Biological Chemistry. 279(20). 20571–20575. 102 indexed citations
19.
Tamura, Yoshiaki, Hideki Adachi, Jun-ichi Osuga, et al.. (2003). FEEL-1 and FEEL-2 Are Endocytic Receptors for Advanced Glycation End Products. Journal of Biological Chemistry. 278(15). 12613–12617. 150 indexed citations
20.
Sekiya, Motohiro, Naoya Yahagi, Takashi Matsuzaka, et al.. (2003). Polyunsaturated Fatty Acids Ameliorate Hepatic Steatosis in Obese Mice by Srebp–1 Suppression. Hepatology. 38(6). 1529–1539. 338 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kazuhisa Tsukamoto Breakdown of academic impact, for papers by Tomohiro Ide Breakdown of academic impact, for papers by Akimitsu Takahashi Breakdown of academic impact, for papers by Pierre‐Damien Denechaud Breakdown of academic impact, for papers by Pascale Bossard Breakdown of academic impact, for papers by Marta Casado Breakdown of academic impact, for papers by Sachiko Tomita Breakdown of academic impact, for papers by Fatiha Nassir Breakdown of academic impact, for papers by Sanja Levak‐Frank
Rankless by CCL
2026